Organization | Government Dental College and Research Institute, Bangalore

Government Dental College and Research Institute, Bangalore Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Founded: Karnataka India (1958)

Organization Overview

First Clinical Trial

2009

NCT02168543

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2017

Timeline

NOW

Now

Alternative names

Government Dental College and Research Institute, Bangalore

Active Ingredients

Drugs in Phase 4 Trials (2)

platelet rich fibrin (5 trials)

rosuvastatin (crestor) (10 trials)

Drugs in Phase 3 Trials (7)

alendronic acid (fosamax) (5 trials)

aloe vera (3 trials)

atorvastatin (lipitor) (8 trials)

boric acid (2 trials)

metformin (glucophage) (1 trial)

simvastatin (zocor) (4 trials)

sitagliptin (januvia) (6 trials)

Drugs in Phase 2 Trials (5)

fluorocalcium phosphosilicate (2 trials)

potassium nitrate (1 trial)

septilin (1 trial)

sodium phosphosilicate (1 trial)

tetrasodium pyrophosphate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Calculi (Phase 2)

Chronic Periodontitis (Phase 3)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Furcation Defects (Phase 4)

Hypersensitivity (Phase 2)

Periodontitis (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 30
# of Trial APIs: 14